SEC Form 4 · accession 0001179110-18-003116
ENDOCYTE INC · ECYT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick Machado
Director
Period of report
Feb 27, 2018
Accepted (ET)
Mar 1, 2018 · 3:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235007
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 27, 2018 | A | 3,750 | $0.00 | A | 3,750 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $4.20 | Feb 27, 2018 | A | 22,500 | A | — | Feb 27, 2028 | Common Stock | 22,500 | 22,500 | D |
Explanation of responses
- F1Represents 3,750 restricted stock units (RSUs) in which 1/3 of the total RSUs will vest on the business day before each of the Issuer's three annual stockholder meetings following February 27, 2018.
- F2Shares subject to the option will vest in three installments, with 1/3 vesting on the business day before each of the Issuer's three annual stockholder meetings following February 27, 2018.